Skip to content

Chronobiological Determinants of Gut Microbiome

Chronobiological Determinants of Gut Microbiome: The Effects of Meal Timing and Eating Frequency

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07303036
Acronym
ChronoNutr
Enrollment
34
Registered
2025-12-24
Start date
2016-10-20
Completion date
2019-06-21
Last updated
2025-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Keywords

morbid obesity, chrononutrition, dietary intake

Brief summary

The aim of this study is to examine how the number of daily eating occasions and the timing of energy intake influence gut microbiome composition in both morbidly obese and non-obese individuals. The analysis is based on baseline data from a case-control study involving 11 non-obese and 23 morbidly obese adults. Participants were excluded if they were younger than 19 or older than 65 years, had an acute or chronic inflammatory condition, had been diagnosed with an infectious disease, cancer, or alcohol dependence, or had used antibiotics within the three months prior to screening.

Detailed description

This study aimed to investigate how the number of daily eating occasions and the timing of energy intake influence gut microbiome composition in morbidly obese and non-obese adults. This case-control study examined the gut microbiota of 23 morbidly obese individuals (BMI \> 40 kg/m²) and 11 non-obese individuals (BMI \< 30 kg/m²). Dietary intake was assessed using 24-hour dietary recall records. From these data, the number of meals, total daily energy intake, and the proportion of energy consumed within specific time intervals (06:00-13:00, 13:00-20:00, and 20:00-06:00) were calculated. Energy intake occurring after 20:00 was defined as nighttime eating. Participant eligibility required individuals to be between 19 and 65 years of age, free from acute or chronic inflammatory diseases, and without diagnoses of infectious diseases, cancer, or alcohol addiction. Additionally, participants were excluded if they had taken antibiotics within the three months preceding the screening.

Interventions

None listed

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
26 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Adults aged 19 to 65 years Morbid obesity (case group) Non-obese status, including lean or pre-obese (control group) Willingness to participate in the study Ability to provide informed consent

Exclusion criteria

Age \< 26 years or \> 60 years Presence of acute or chronic inflammatory diseases Diagnosis of infectious diseases History of cancer Alcohol addiction Use of antibiotics within 3 months prior to screening

Design outcomes

Primary

MeasureTime frameDescription
Gut microbial profiles of participantsBaselineGut microbial profiles of participants at phylum and sub-phylum levels
Meal frequency of participantsBaselineNumber of meals consumed per day
Total daily energy intakeBaselineTotal daily energy intake assessed from dietary data (kcal/day)
Distribution of energy intake by time of dayBaselinePercentage of total daily energy intake consumed during predefined time periods of the day (e.g., morning, afternoon, evening, night)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026